Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.86 |
| ▸ | MAPT | P10636 | 6/20 | 0.86 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.86 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.86 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.86 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.86 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7012980 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL13915193 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL7793770 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL14461271 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL3478291 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL69032 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL12714629 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL19139645 | 0.98 | ALDH1A1 (0.82) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL13050027 | 0.98 | ALDH1A1 (0.82) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 | |
| SCHEMBL22328747 | 0.98 | ALDH1A1 (0.82) | ALDH1A1CYP3A4MAPTTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458182-B2 | Silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzophospholes, and use thereof in organic electronics | BASF SE (DE) | 2016-10-04 | — | — | US | disclosed |
| EP-2688889-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-01-29 | — | — | EP | disclosed |
| WO-2012130709-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-10-04 | — | — | WO | disclosed |
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | DDT, CDKL1, CDK2 | ALDH1A1 750/4885CYP3A4 1170/4885MAPT 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.